CKD Anemia of Renal Disease Management — free guideline decision tool
This tool manages anemia of CKD by hemoglobin and iron status (ferritin/TSAT) and dialysis modality, directing iron and ESA/HIF-PHI.
Open guideline tool →Guideline-based
Implements the decision logic from published clinical guidelines.
Runs in your browser
No installation. Enter the patient's values and get a guideline recommendation instantly.
Data stays local
Nothing is uploaded. Results are for licensed clinicians only.
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| Hemoglobin Hb | 95 g/L |
|---|---|
| Serum ferritin SF | 120 ng/mL |
| Transferrin saturation TSAT | 18 % |
| Dialysis modality | Non-dialysis / peritoneal dialysis |
→DispositionStart anemia correction
- Iron status & supplementation：Iron deficiency present (non-dialysis/PD): give iron first (oral or IV for non-dialysis, usually IV for dialysis; avoid IV iron in active infection/bacteremia)
- ESA/HIF-PHI：Start an erythropoiesis-stimulating agent (ESA, first-line) or HIF-PHI (roxadustat): correct iron deficiency and reversible factors (inflammation, bleeding, nutrition, etc.) and exclude other anemia causes first
- Target：avoid an overly rapid Hb rise (magnitude [pending update])
Common questions
What is CKD Anemia of Renal Disease Management?
This tool manages anemia of CKD by hemoglobin and iron status (ferritin/TSAT) and dialysis modality, directing iron and ESA/HIF-PHI.
How is CKD Anemia of Renal Disease Management calculated? What is the core formula?
Iron deficiency (thresholds [pending update]) → correct iron first, then start ESA/HIF-PHI; avoid an overly rapid Hb rise.
When is CKD Anemia of Renal Disease Management used?
Use to decide on iron supplementation, ESA or HIF-PHI initiation, avoiding a rapid Hb rise.
How should CKD Anemia of Renal Disease Management results be interpreted?
The Hb upper target is hidden: it conflicts with KDIGO 2025 (PMID 42735412; ESA maintenance Hb <115 g/L). [Pending update] The guideline cited on this page has a newer version or is over 5 years old (KDIGO 2025, PMID 42735412); content awaits review against the current version. Unsourced specific doses are hidden; follow current guidelines and local protocols. [Pending update] Unsourced specific doses/regimens on this page are temporarily hidden pending item-by-item review against the cited guideline texts.
What are the key clinical points for CKD Anemia of Renal Disease Management?
Iron deficiency and reversible factors are corrected before starting an ESA, and an excessively rapid hemoglobin rise is avoided. (original synthesis · not guideline verbatim) Hemodialysis uses a higher ferritin threshold than non-dialysis/PD.
What are the limits and cautions when using CKD Anemia of Renal Disease Management?
For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
Does CKD Anemia of Renal Disease Management upload patient data? Where is it calculated?
Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
How is CKD Anemia of Renal Disease Management calculated in practice? Can you show a worked example?
Inputs: Hemoglobin Hb 95 g/L, Serum ferritin SF 120 ng/mL, Transferrin saturation TSAT 18 %, Dialysis modality Non-dialysis / peritoneal dialysis → Result: Disposition Start anemia correction（Iron status & supplementation: Iron deficiency present (non-dialysis/PD): give iron first (oral or IV for non-dialysis, usually IV for dialysis; avoid IV iron in active infection/bacteremia), ESA/HIF-PHI: Start an erythropoiesis-stimulating agent (ESA, first-line) or HIF-PHI (roxadustat): correct iron deficiency and reversible factors (inflammation, bleeding, nutrition, etc.) and exclude other anemia causes first, Target: avoid an overly rapid Hb rise (magnitude [pending update])）
Run CKD Anemia of Renal Disease Management now
This tool manages anemia of CKD by hemoglobin and iron status (ferritin/TSAT) and dialysis modality, directing iron and ESA/HIF-PHI.
Open guideline tool →For licensed clinicians. Not a substitute for clinical judgement.
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.